Latest "GUERBET Revenue June 2016 EU376 million" News Stories

12:35 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "GUERBET Revenue June 2016 EU376 million" found in our extensive news archives from over 250 global news sources.

More Information about GUERBET Revenue June 2016 EU376 million on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about GUERBET Revenue June 2016 EU376 million for you to read. Along with our medical data and news we also list GUERBET Revenue June 2016 EU376 million Clinical Trials, which are updated daily. BioPortfolio also has a large database of GUERBET Revenue June 2016 EU376 million Companies for you to search.

Showing "GUERBET Revenue June 2016 EU376 million" News Articles 1–25 of 13,000+

Monday 18th March 2019

New Study: Over-the-Counter (OTC) Products Used by Millions of Americans Saves Healthcare System Billions Annually

Cost savings from reduced need for clinical visits and prescription drugs due to OTCs saves U.S. health system $146 billion annually Today, the Consumer Healthcare Products Association (CHPA) released a new study, “Value of OTC Medicines to the U.S. Healthcare System,” that found, on average, each dollar spent on over-the-counter (OTC) medicines sa...

CURE Media Group Named the 2019 Ovarian Cancer Heroes®

CURE Media Group’s flagship product, CURE® magazine, which reaches over a million patients, survivors and caregivers and is dedicated to providing cancer updates, announced the 2019 Ovarian Cancer Heroes® who have made a difference in the field. The event was held during the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer. This...

Canndescent™ Completes the World’s First Commercial Scale Solar Project in Cannabis

Company creates a more sustainable growing model it calls greendoor™, uniting renewable, solar energy with the water-efficiency of indoor growing Cementing its role as an industry trailblazer, Canndescent™ has completed the cannabis industry’s first, commercial-scale solar project, powering its indoor production facility in Desert Hot Springs, CA...

Cortney Johnson Joins ESO as Chief Financial Officer

Johnson brings experience and expertise managing complex finance strategies for high-growth technology companies ESO, the leading data and software company serving emergency medical services (EMS), fire departments and hospitals, today announced Cortney Johnson has been named Chief Financial Officer. Johnson brings nearly 20 years of financial l...

Mogrify receives Innovate UK funding to accelerate regenerative cell therapies

A UK-based cell therapy company has been awarded almost half a million pounds in funding from Innovate UK.

CardioMech Expands Mitral Leadership Team

Company Elects New Directors, Board Advisor, and Appoints VP Finance on Heels of Recent $2.5 Million Financing CardioMech AS, a privately held company developing a transcatheter mitral valve repair technology, today announced it has expanded its leadership team with the election of two new board directors − Kathleen Tune of

Advantage Capital Invests $6.5 Million in Danimer Scientific, Supporting Company’s Growth in Rural Georgia

Danimer looks to expand existing HQ and bring new jobs to rural Georgia, underscoring the economic and community development impact of the Georgia Agribusiness and Rural Jobs Act (GARJA) Advantage Capital today announced a $6.5 million investment in Danimer Scientific, a leading biotechnology company producing biodegradable and compostable polymers use...

Diagnostics Data Analytics Company Diaceutics to List on London Stock Exchange

Company seeking £53M IPO on London Stock Exchange junior market, AIM (Alternative Investment Market) Diaceutics expects the addressable market for its specific services to grow to US$2.5BN by 2023 Diaceutics plc, a revenue-generating and profitable diagnostics data analytics and implementation services company which ...

Karuna Snags $68 Million to Support Schizophrenia Treatment Development

Karuna Snags $68 Million to Support Schizophrenia Treatment Development

WomenHeart Welcomes Celina Gorre as New Chief Executive Officer

WomenHeart: The National Coalition for Women with Heart Disease, announces Celina Gorre as its new Chief Executive Officer. This press release features multimedia. View the full release here: (Photo: Business Wire) “Celina brings more than 15 years of experience in global health, corporat...

P&G Sets New Goal to Deliver 25 Billion Liters of Clean Drinking Water to Families in Need Worldwide

After achieving its 2020 goal of delivering 15 billion liters one year early, the Company increases its target to 25 billion liters of clean water by 2025 This World Water Day, Procter & Gamble (P&G) is celebrating the achievement of its 2020 goal of delivering 15 billion liters of clean drinking water through its non-profit Children’s Safe D...

Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space

A recent study in Frontiers in Bioengineering and Biotechnology showed uBiome and its executives as top inventors in the microbiome industry. SAN FRANCISCO (PRWEB) March 18, 2019 uBiome, the leader in microbial genomics, has the largest patent portfolio in the microbiome industry and the third highest quality portfolio following Seres Health and Nestle, as published in Frontiers in Bioengineering...

Shield Compliance Launches Shield Data Hub to Streamline Cannabis Banking Compliance and Risk Management

New executive leadership and funding will enable company to expand operations to all 33 states with legalized cannabis. Shield Compliance (, the industry’s only purpose-built AML/BSA compliance management and payment integrator system for banking legal marijuana-related businesses (MRBs), today announced the availabilit...

vTv Therapeutics Announces $15 Million of Class A Common Stock Financings

Proceeds Will Fund Start-Up Activities for Current and Future Clinical Trials vTv Therapeutics Inc. (Nasdaq:VTVT) (the “Company”) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered direct offering (the “Registered Direct Offering”) of 3,636,364 shares of...

3M Announces New Business Segments and Leadership Appointments

New Structure Increases Customer Focus, Agility and Productivity 3M today announced the realignment of the company from five to four business segments. The new alignment will enable the company to better serve global customers and markets. “We are continuing to advance 3M into the future, and today’s actions will strengthen our ability to ...

Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD

- License and Collaboration Agreement was signed between OliX and Théa for OLX301A program, a novel treatment for dry and wet age-related macular degeneration. - OliX to receive an upfront payment of 2 million euro, and eligible to receive milestones, plus royalty for the development and commercialization in

Hilton Brands to Recycle 1 Million Bars of Soap by Global Handwashing Day

Partnering with Clean the World, Hilton’s participating brands will recycle soap and donate to communities in need around the world Hilton’s (NYSE: HLT) Hilton Garden Inn, Hampton by Hilton and All Suites brands are launching the Clean the World Challenge in partnership with Clean

Mogrify awarded $555,000 USD (£420,000 GBP) Innovate UK funding to accelerate regenerative cell therapies. Project to focus on data-driven cell conversions to produce cell therapies with potential application in wound healing, and oncology immunotherapy

  Cambridge, UK, 18th March 2019: Cell Mogrify Ltd (Mogrify), a UK company aiming to transform the future development of cell therapies, today announced that it has been awarded $555,000 USD (£420,000 GBP) funding from Innovate UK, the UK’s innovation agency, through the investment accelerator for innovation in precision medicine. This funding will support the application of M...

CSPC Pharmaceutical Announces 2018 Annual Results

Profit Attributable To Shareholders Increased 31.9% to HK$3,655 Million Innovative Drug Business Continued to Deliver Strong Growth R&D Deployment Further Improved HONG KONG, March 18, 2019 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group"), a leading pharmaceutical company...

Motus GI Expands Intellectual Property Portfolio with Issuance of New U.S. Patent for the Pure-Vu® System

Issued patent further bolsters Company’s intellectual property estate, supporting strategic pathway for Pure-Vu® System to become standard of care for inpatient colonoscopy Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and enhan...'s SalaryScan Survey Finds Interventional Radiologists on Top

Results from a new SalaryScan survey of compensation in medical imaging published by radiology portal TUCSON, Ariz. (PRWEB) March 18, 2019 Interventional radiologists received the highest salaries among all types of diagnostic and interventional radiologists in 2018, according to a new SalaryScan survey of compensation in medical imaging published by radiology portal

Cold Genesys Closes $22 Million Series C Financing

Investment to Advance Clinical Development of Oncolytic Immunotherapies in Bladder Cancer and other Solid Tumors Cold Genesys, Inc., a clinical-stage biopharmaceutical company focused on the development of novel immunotherapies, today announced the closing of a $22 million Series C preferred stock financing. New investors participated in the rou...

Mr. Ron Smith Joins Covalon’s Board of Directors and is Appointed Chair of the Audit Committee

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announced that Mr. Ron Smith has joined Covalon’s Board of Directors and has been appointed Chair of Covalon’s Audit Committee. Mr. Smith (FCPA, FCA, ICD.D) is an experienced independent director with ...

Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2018 Results

Conference Call to Discuss Results Today at 7:30 a.m. CT / 8:30 a.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the fourth quarter and year ended December 31, 2018. Highlights ...

Horizon Pharma plc Wins PR News CSR Award for Partnership with Perspectives Math and Science Academy

Horizon Pharma plc (Nasdaq: HZNP) announced today that it has won a PR News CSR Award in the Corporation category for its impactful partnership with Chicago-based charter school, Perspectives Math and Science Academy (MSA). A video highlighting the partnership can be found here. PR News’ CSR Awards celebrate organizations committed to mak

Quick Search


News Quicklinks